Divalproex Sodium Tablet, Delayed Release
Product Images NDC 70518-3055

13 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-3055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Divalproex Str)

Chemical Structure (Divalproex Str)
Chemical structure of Divalproex Sodium showing a polymeric structure with branched alkyl chains, carboxylate groups, and sodium ion. The diagram depicts repeating units indicated by 'n' representing the polymer nature of the compound.*
FDA Label Image

Figure 1 (Divalproex Fig1)

Figure 1 (Divalproex Fig1)
A bar chart comparing the efficacy percentages of placebo (PBO) and divalproex sodium delayed-release tablets (DVPX) in two studies, with Study 1 measured by YMRS and Study 2 by MRS. The chart shows higher response percentages for DVPX (60% and 58%) compared to placebo (26% and 29%), with statistical significance indicated (p < 0.05).*
FDA Label Image

Figure 2 (Divalproex Fig2)

Figure 2 (Divalproex Fig2)
A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium Delayed-Release Tablets and placebo across a patient population percentage. The vertical axis shows percent change with labels for improvement and worsening, while the horizontal axis shows the percentage of patients from 0% to 100%. The solid line represents Divalproex Sodium Delayed-Release Tablets, showing generally greater improvement, and the dotted line represents placebo.*
FDA Label Image

Figure 3 (Divalproex Fig3)

Figure 3 (Divalproex Fig3)
A line graph titled Figure 3 depicting the % reduction in CRS rate on the vertical axis and % of patients on the horizontal axis. Two lines compare High Dose and Low Dose groups, illustrating patient response distribution from worsening to improvement.*
FDA Label Image

Figure 4 (Divalproex Fig4)

Figure 4 (Divalproex Fig4)
Bar chart titled 'Mean 4-week Migraine Rates' compares migraine rates between placebo and Divalproex Sodium delayed-release tablets in two clinical studies. The vertical axis measures migraine rates from 0 to 6. Study 1 shows higher migraine rates for placebo than for Divalproex Sodium at a mean dose of 1,087 mg/day. Study 2 shows similar trends with doses of 500 or 1,000 mg/day.*
FDA Label Image

Mm1 (Divalproex Sodium 250mg 70518 3055 00)

Mm1 (Divalproex Sodium 250mg 70518 3055 00)
Label for Divalproex Sodium delayed-release tablets, 250 mg strength. The package contains 30 oral tablets. The label includes NDC number 70518-3055-00, repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer is Rising Pharma, Inc., Allendale, NJ. Storage instructions note temperature ranges of 20-25°C with permitted excursions.*
FDA Label Image

Mm2 (Divalproex Sodium 250mg 70518 3055 01)

Mm2 (Divalproex Sodium 250mg 70518 3055 01)
Divalproex Sodium 250 mg delayed-release oral tablets in a package of 100 tablets. The label shows the product name, strength, dosage form, and quantity, repackaged by RemedyRepack Inc. It includes a QR code, manufacturer information (Rising Pharma, Inc., Allendale, NJ), and storage directions.*
FDA Label Image

Mm3 (Divalproex Sodium 250mg 70518 3055 02)

Mm3 (Divalproex Sodium 250mg 70518 3055 02)
Label for Divalproex Sodium delayed-release tablet, 250 mg, single tablet quantity. The label includes the NDC 70518-3055-02, repackaged by RemedyRepack Inc., with manufacturer Rising Pharma, Inc. It features dosage form and strength, storage instructions, and a QR code on a white background with purple accents.*
FDA Label Image

Mm4 (Divalproex Sodium 250mg 70518 3055 03)

Mm4 (Divalproex Sodium 250mg 70518 3055 03)
Divalproex Sodium 250 mg delayed-release tablets in a box of 100 tablets. The label includes the NDC number 70518-3055-03 and indicates oral administration. It is repackaged by RemedyRepack Inc., Indiana, PA. The label advises usual dosage refer to insert, storage between 20-25°C with permitted excursions, and to keep the medication out of reach of children.*
FDA Label Image

Mm5 (Divalproex Sodium 250mg 70518 3055 04)

Mm5 (Divalproex Sodium 250mg 70518 3055 04)
Label for Divalproex Sodium 250 mg delayed-release tablet, oral use, with a quantity of 1 tablet. The label includes the NDC number 70518-3055-04 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Manufacturer information shows Rising Pharma, Inc., Allendale, NJ. Storage instructions and usual dosage advisories are noted.*
FDA Label Image

Mm6 (Divalproex Sodium 250mg 70518 3055 05)

Mm6 (Divalproex Sodium 250mg 70518 3055 05)
Divalproex Sodium 250 mg delayed-release tablets packaging label. The bottle contains 60 tablets. Labeler is RemedyRepack Inc., Indiana, PA. The original manufacturer listed is Rising Pharma, Inc., Allendale, NJ. The label includes storage instructions and a QR code.*
FDA Label Image

Mm7 (Divalproex Sodium 250mg 70518 3055 06)

Mm7 (Divalproex Sodium 250mg 70518 3055 06)
Divalproex Sodium 250 mg delayed-release tablets packaging label showing a quantity of 30 tablets. The label includes the NDC number 70518-3055-06, repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer listed is Rising Pharma, Inc., Allendale, NJ. Storage instructions specify keeping the medication out of children's reach and storing at 20-25°C with permitted excursions to 15-30°C.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Divalproex Sodium 250 mg delayed-release oral tablets. The label indicates a quantity of 30 tablets and specifies that the product is prescription only (RX ONLY). It includes the NDC number 70518-3055-00 and repackaging information by RemedyRepack Inc., Indiana, PA. The manufacturer is noted as Rising Pharma, Inc., Allendale, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.